美國居民不適用 XM 服務。
K
K

Kroger

交易方向

交易者脈動

技術摘要

小時

財經新聞

US FTC preparing to sue to block $8.5 bln takeover of Capri by Tapestry, NYT Dealbook reports

UPDATE 3-US FTC preparing to sue to block $8.5 bln takeover of Capri by Tapestry, NYT Dealbook reports Adds background and FTC's response in paragraphs 5,7 & 9, updates shares in paragraph 10 By Savyata Mishra April 17 (Reuters) - The U.S. Federal Trade Commission (FTC) is preparing to sue to block Coach parent Tapestry's TPR.N $8.5 billion deal to buy Michael Kors owner Capri CPRI.N , NYT Dealbook reported on Wednesday, citing people familiar with the matter.
K

U.S. STOCKS US Health Insurers, Palisade Bio, Dynatronics

BUZZ-U.S. STOCKS ON THE MOVE-US Health Insurers, Palisade Bio, Dynatronics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes were on track for a higher open on Tuesday, with health insurers leading the charge following upbeat results from industry major UnitedHealth, while investors kept tabs on the conflict in the Middle East.
B
C
J
K
S
T
U
L

U.S. STOCKS Macatawa Bank, Kroger, International Paper

BUZZ-U.S. STOCKS ON THE MOVE-Macatawa Bank, Kroger, International Paper Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures edged lower on Tuesday, weighed by elevated Treasury yields as investors remained wary of the conflict in the Middle East, turning the lens on company earnings to gauge the strength of the economy.
B
J
K
S
U
L

Wells Fargo upgrades Kroger to 'overweight' on improving fundamentals

BUZZ-Wells Fargo upgrades Kroger to 'overweight' on improving fundamentals ** Shares of department store operator The Kroger Co KR.N up 1.05% in premarket trade ** Wells Fargo upgrades stock to 'overweight' from 'equal weight,' cites improving fundamentals and "potential for a huge buyback" ** Its new rating is an equivalent to 'buy' as per LSEG da
K

Pfizer’s Wyeth reaches $39 million settlement in Effexor XR antitrust case

Pfizer’s Wyeth reaches $39 million settlement in Effexor XR antitrust case By Mike Scarcella April 10 (Reuters) - Pfizer PFE.N subsidiary Wyeth has agreed to pay $39 million to resolve claims from drug purchasers that it conspired with rival Teva to delay launching a less-expensive version of the antidepressant drug Effexor XR. Plaintiffs’ lawyers for Rochester Drug Co-Operative, Stephen L.
K
P
T
W

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明